Insider Holders & Insider Ownership - RespireRx Pharmaceuticals Inc. (RSPI)

List of insiders holdings for RespireRx Pharmaceuticals Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time		 Shares Owned
Directly
Indirectly		 Total
Shares Owned		 Filing
1 Margolis Jeff Eliot
SVP, CFO, Secret'y & Treasurer
10% Owner		 2020-10-02 15:47:00 171
107,048,385		 107,048,556 Form 4
2 AURORA CAPITAL LLC
Member of a 10% owner group		 2013-06-19 16:32:17 24,200,507
0		 24,200,507 Form 13D
3 ORIGIN VENTURES II LP
Origin Ventures II Management LLC
BARRON BRUCE N
Miller Steven N.
10% Owner		 2013-06-19 16:35:17 24,200,507
0		 24,200,507 Form 13G
4 samyang optics co. ltd
Samyang Value Partners Co. Ltd.
10% Owner		 2013-06-19 16:39:22 22,113,831
0		 22,113,831 Form 13D
5 IllinoisVentures GP LLC
ILLINOIS EMERGING TECHNOLOGIES FUND LP
10% Owner		 2012-08-20 16:48:41 20,334,546
0		 20,334,546 Form 13G
6 Jones Timothy L.
CEO and President		 2020-10-02 15:51:43 8,818,154
0		 8,818,154 Form 4
7 MacFarlane Katie
Director		 2020-10-02 15:50:56 5,000,000
0		 5,000,000 Form 4
8 Purcell Richard David Jr.
SVP - Research and Development		 2020-08-04 14:25:58 5,000,000
0		 5,000,000 Form 4
9 Radin Marc M
Controller		 2014-04-16 20:14:05 4,000,000
0		 4,000,000 Form 4
10 STOLL ROGER G PHD
Executive Chairman		 2012-08-14 16:05:05 3,083,334
0		 3,083,334 Form 4
11 AURORA CAPITAL CORP
Member of 10% owner group		 2013-04-01 18:01:29 0
2,971,792		 2,971,792 Form 3
12 T. Morgen Capital LLC
Member of 10% owner group		 2013-04-01 17:34:52 0
2,971,792		 2,971,792 Form 3
13 COLEMAN JAMES H
Sr. VP, Business Development		 2012-08-14 16:04:28 2,083,334
0		 2,083,334 Form 4
14 Dickason David
SVP of Pre-Clinical Prod. Dev.		 2020-10-06 15:20:38 2,000,000
0		 2,000,000 Form 4
15 Carley David W.
Director		 2012-08-20 16:12:32 1,899,158
0		 1,899,158 Form 4
16 MANUSO JAMES S J
President and CEO		 2017-12-12 18:49:47 1,198,149
0		 1,198,149 Form 4
17 Letendre Peter
Director		 2012-08-20 16:05:12 684,031
0		 684,031 Form 4
18 Cohen Kenneth M
Member of 10% owner group		 2013-04-01 18:20:30 656,755
0		 656,755 Form 3
19 Varney Mark A
President and CEO		 2009-08-24 19:28:31 588,000
0		 588,000 Form 4
20 Benedik John F
Director		 2012-08-07 16:11:20 493,333
0		 493,333 Form 4
21 JOHNSON M ROSS
Director		 2012-08-07 16:16:07 428,333
0		 428,333 Form 4
22 DRAKE PETER F
Director		 2012-08-07 16:15:11 406,667
0		 406,667 Form 4
23 CASAMENTO CHARLES J
Director		 2012-08-07 16:13:17 406,667
0		 406,667 Form 4
24 MESSINGER MARIA S
Chief Financial Officer		 2009-08-24 19:22:15 380,000
0		 380,000 Form 4
25 ALLNUTT ROBERT
Director		 2012-08-07 16:10:34 363,333
0		 363,333 Form 4
26 Chizzik Steven
Member of 10% owner group		 2013-04-01 18:07:36 330,199
0		 330,199 Form 3
27 COTMAN CARL W
Director		 2012-08-07 16:14:00 276,667
0		 276,667 Form 4
28 WEINGARTEN ROBERT N
EVP & Chief Financial Officer		 2017-01-20 21:10:36 216,156
0		 216,156 Form 4
29 SAPIRSTEIN JAMES
Director		 2017-12-12 19:38:21 134,269
0		 134,269 Form 4
30 Mansbach Harry H
Chief Medical Officer		 2005-12-05 12:28:13 100,000
0		 100,000 Form 4
31 ROGERS GARY ALLEN
Sr VP, Pharmaceutical Research		 2007-02-07 19:33:38 0
58,399		 58,399 Form 5
32 Tran Pierre V
Chief Medical Officer		 2009-08-24 19:24:53 50,000
0		 50,000 Form 4
33 TOLLEFSON GARY D
Director		 2008-02-13 19:14:23 30,000
0		 30,000 Form 4
34 Lippa Arnold
Exec. Chairman & CSO		 2020-10-02 15:47:42 100
0		 100 Form 4
35 Johnson Steven Andrew
VP, Preclinical Development		 2010-02-02 20:46:54 0
0		 0 Form 5
36 Hwang Moogak
Director		 2012-08-09 18:24:37 0
0		 0 Form 3
37 HYER KATHRYN BURRER
Director		 2012-08-14 13:42:18 0
0		 0 Form 3